ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.098,09
-0,50%
S&P 500
5.277,51
0,80%
US Dollar vs BRL
5,2463
0,01%
Bitcoin
67.583,92
0,15%
Brent Oil
81,295
0,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Sonnet BioTherapeutics Holdings Inc (SONN)

  7. Sonnet BioTherapeutics Holdings Inc (SONN) Notícias

SONN

Sonnet BioTherapeutics (SONN)

Sonnet BioTherapeutics Holdings Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:SONN
DataHoraFonteTítuloCódigoCompanhia
28/05/202409:00GlobeNewswire Inc.Sonnet BioTherapeutics to Present SB221 as a Trial in Progress at the ASCO 2024 Annual MeetingNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
22/05/202408:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
17/05/202401:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
16/05/202417:16Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
15/05/202417:06Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
14/05/202417:26Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
02/01/202418:19Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
22/12/202318:31Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
14/12/202319:02Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
27/10/202321:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
26/10/202310:00Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
19/09/202317:30Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
07/09/202312:01Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
22/08/202309:30Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
21/08/202317:31Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
07/08/202317:20Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
07/08/202317:15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
28/07/202317:30Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
17/07/202313:10Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
30/06/202310:00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
30/06/202309:41Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
30/06/202309:40Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
29/06/202318:28Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
29/06/202318:27Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
14/06/202315:43Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
31/05/202309:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
10/05/202308:31Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
09/02/202318:16Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
08/02/202308:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
07/02/202319:30Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:SONN

Seu Histórico Recente

EU
FRSG00014HY6
SG Issuer Sg Issuer Mc D...
TSXV
DOG
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados